I just realised that I left of the link to the statement as quoted:
"Mesoblast presented consistently high survival in patients treated in RYONCIL, in children with SR-aGVHD in the EAP between 2008-2015, in the Phase 3 trial MSB-GVHD001 between 2015-2018, and in the Emergency Investigational New Drug (EIND) protocol from 2015-2023."
https://investorsmedia.mesoblast.com/static-files/adfc1ba0-bd4d-47bd-b0a0-a0b3516b0520
Usually I provide the link with the quote, but must have forgotten this time.
I just realised that I left of the link to the statement as...
-
- There are more pages in this discussion • 42 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
26.0¢ |
Change
0.015(6.12%) |
Mkt cap ! $46.70M | |||
| Open | High | Low | Value | Volume |
| 25.0¢ | 26.0¢ | 25.0¢ | $29.56K | 116.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 36470 | 25.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 26.0¢ | 5000 | 1 |
View Market Depth
| Last trade - 12.06pm 30/07/2024 (20 minute delay) ? |
| CYP (ASX) Chart |